Technology ID
TAB-4623
Enterobacteriaceae Strains for Accelerate Diagnostics Licensing
E-Numbers
E-031-2017-0
Lead Inventor
Rasheed, James
Lead IC
CDC
ICs
CDC
Applications
Therapeutics
Research Materials
Diagnostics
Therapeutic Areas
Infectious Disease
Development Stages
Pre-Clinical (in vitro)
Research Products
Plasmids/Vectors
Human Cell Lines
This technology includes a repository of unique Enterobacteriaceae isolates for various therapeutic and diagnostic uses:
Enterobacter cloacae (Known Acquired Resistance: NDM-1) – Strain 0038
Klebsiella pneumoniae (Known Acquired Resistance: CTX-M-14) – Strain 0079
Citrobacter freundii (Known Acquired Resistance: KPC-2) – Strain 0116
Escherichia coli (Known Acquired Resistance: NDM-1) – Strain 0118
Klebsiella pneumoniae (Known Acquired Resistance: NDM-1) – Strain 0148
Escherichia coli (Known Acquired Resistance: NDM-5) – Strain 0150
Escherichia coli (Known Acquired Resistance: NDM-7) – Strain 0162
Commercial Applications
The isolates can be used for therapeutics, diagnostics, and commercial research tool use.
Competitive Advantages
Repository of unique isolates not currently available in the market.
Licensing Contact: